| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Neuroscience | 347 | 17 | 18 | 7 |
| Psychology | 641 | 26 | 48 | 11 |
| Medicine | 2596 | 20 | 33 | 9 |
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology investigates studies in Psychiatry, Internal medicine, Schizophrenia, Depression (differential diagnoses) and Major depressive disorder. The Psychiatry study featured in the journal draws parallels with the field of Pediatrics. The concepts on Internal medicine presented in the journal can also apply to other research fields, including Gastroenterology, Endocrinology and Oncology.
The studies in Antipsychotic, Clozapine, Atypical antipsychotic and Positive and Negative Syndrome Scale under the umbrella field of Schizophrenia overlap with concepts in In patient. Antipsychotic and Risperidone are closely related fields of research discussed in the journal. The research on Major depressive disorder featured in Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology combines topics in other fields like Antidepressant, Mood disorders, Clinical psychology and Rating scale.
It links adjacent topics like Bipolar disorder with Mood.
The published articles mainly deal with areas of study such as Psychiatry, Schizophrenia, Cognition, Pharmacology and Depression (differential diagnoses). The journal articles feature Psychiatry research that overlaps with concepts in Alternative medicine. The published articles explore topics in Schizophrenia which can be helpful for research in disciplines like Internal medicine, Neuroscience and Bioinformatics.
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology is organized to address concerns in the fields of Internal medicine, Major depressive disorder, Schizophrenia, Depression (differential diagnoses) and Adverse effect. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology explores topics in Internal medicine which can be helpful for research in disciplines like Endocrinology, Rating scale, Gastroenterology, Antipsychotic and Positive and Negative Syndrome Scale. While Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology focused on Major depressive disorder, it was also able to explore topics like Bipolar disorder, Anxiety, Neuroimaging, Depressive symptoms and Biomarker (medicine).
The research on Schizophrenia tackled can also make contributions to studies in the areas of Varenicline, Disease and Audiology. The journal facilitates discussions on Depression (differential diagnoses) that incorporate concepts from other fields like Sleep disorder, Pharmacotherapy and Pediatrics. The featured Sertraline research is covered under the field of Psychiatry.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 6.45% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 34.48% were posted by at least one author from the top 10 institutions publishing in the journal. Another 15.52% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 17.24% of all publications and 32.76% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
An additional section that could enhance the depth of the article, following the Google Search Quality Guidelines, would be a discussion on potential career pathways one can pursue after studying Clinical Psychopharmacology and Neuroscience. This would serve as practical guidance for those considering a career in this field. The field of Clinical Psychopharmacology and Neuroscience is broad and offers many different career paths. Becoming a trained and licensed professional in this field requires dedication, commitment, and a passion for understanding complex, neurological conditions. Training in these fields is demanding and requires a deep understanding of Psychopharmacology, Psychiatry, Schizophrenia, and other related sub-disciplines. After gaining this knowledge base, professionals can choose to specialize in areas like Internal Medicine, Endocrinology, or Oncology. For instance, one can become a Speech-Language Pathologist, a career that often interfaces with psychopharmacology and neurology. This professional helps patients suffering from conditions that impair their ability to communicate or swallow. These could be conditions arising from disorders like Autism, Stroke, Brain Injury, or a Mental Health Disorder. To become a Speech-Language Pathologist, one must meet specific study and licensing requirements. For example, the kansas slp license requirements provides a clear pathway to entering this rewarding profession. Choosing a career path in Clinical Psychopharmacology and Neuroscience is a decision that can lead to a fulfilling, impactful life. The ability to treat neurological disorders and support individuals in their path to better health is the ultimate reward in this profession.
Domenico De Berardis;Gabriella Rapini;Luigi Olivieri;Agostina Giardini
(2021)Ju-Wan Kim;Robert Stewart;Robert Stewart;Seung-Ji Kang;Sook-In Jung
(2020)Mario Fahed;David C. Steffens
(2021)Po Han Chou;Yen Feng Lin;Ming Kuei Lu;Hsin An Chang
(2021)Chiara Fabbri;Alessandro Serretti
(2020)Heather E. Soder;Amber M. Berumen;Kira E. Gomez;Charles E. Green
(2020)Hyoun-Wook Kim;Cheolmin Shin;Seung-Hoon Lee;Changsu Han
(2021)For those interested in advancing their healthcare careers, exploring related online degrees offers flexible and accessible options. Registered nurses aiming to boost their qualifications can find programs like online rn to bsn no clinicals which offer convenience without sacrificing essential learning.
For nurses seeking to further specialize, the Doctor of Nursing Practice (DNP) degree provides advanced clinical and leadership training. Prospective students may want to explore the medical assistant programs accelerated for swift entry into healthcare, or consider the shortest dnp program options to achieve their goals faster.
Additionally, resources highlighting the dnp program pathways can help prospective students understand the varying levels of rigor and time commitment involved, allowing them to choose a track that best matches their lifestyle and career aspirations.
With many accelerated and flexible programs available, healthcare professionals have numerous pathways to upgrade their skills and certifications while balancing personal and professional demands.
